OCX: OncoCyte Corporation Stock

by  •  • Comments Off on OCX: OncoCyte Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 86.94
Enterprise Value ($M) 78.31
Book Value ($M) -12.27
Book Value / Share -0.43
Price / Book -7.08
NCAV ($M) -35.60
NCAV / Share -1.24
Price / NCAV -2.44

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.81
Return on Equity (ROE) -2.37

Liquidity (mrq)
Quick Ratio 1.56
Current Ratio 1.62

Balance Sheet (mrq) ($M)
Current Assets 11.76
Assets 35.08
Liabilities 47.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.88
Operating Income -23.25
Net Income -60.66
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.71
Cash from Investing -0.51
Cash from Financing 20.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-04 13G/A Bio-rad Laboratories, Inc. 9.70 82.94
02-14 13G/A AWM Investment Company, Inc. 7.50 73.18
02-10 13D/A Broadwood Partners, L.p. 40.20 127.60
12-27 13G/A Smith Patrick W 10.50
11-14 13G Pura Vida Investments, Llc 4.57 -12.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-27 1,881 18,516 10.16
2025-03-25 14,419 81,772 17.63
2025-03-24 2,650 29,697 8.92

(click for more detail)

Similar Companies
NVCT – Nuvectis Pharma, Inc. OCEA – Ocean Biomedical, Inc.
OCGN – Ocugen, Inc. OKYO – OKYO Pharma Limited
ONCO – Onconetix, Inc.


Financial data and stock pages provided by
Fintel.io